CORV
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
CORV
Delisted
CORV was delisted on the 26th of May, 2020.
36 hedge funds and large institutions have $40.9M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2018 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $216K
Holders
36
Holding in Top 10
–
Calls
–
Puts
$216K
Top Buyers
| 1 | +$580K | |
| 2 | +$567K | |
| 3 | +$333K | |
| 4 |
CPA
Columbia Pacific Advisors
Seattle,
Washington
|
+$251K |
| 5 |
PCM
Prelude Capital Management
New York
|
+$170K |
Top Sellers
| 1 | -$1.18M | |
| 2 | -$587K | |
| 3 | -$173K | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
-$90.5K |
| 5 |
Two Sigma Investments
New York
|
-$84K |